Cornelius Toma
Internal Medicine · Mercerville, NJNPI 1003966482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.
Across 187 payments — averaging $10.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$384
- AstraZeneca$238
- AbbVie$181
- Sanofi-aventis U.S. LLC$158
- Takeda Pharmaceuticals U.S.A., Inc.$127
- Lilly USA, LLC$123
- plus $775 from 18 others
What the payments were for
- Food & beverage$1,97399%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 38 | $384 |
| AstraZeneca | 17 | $238 |
| AbbVie | 26 | $181 |
| Sanofi-aventis U.S. LLC | 13 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $127 |
| Lilly USA, LLC | 13 | $123 |
| Johnson & Johnson | 12 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $117 |
| GSK | 7 | $90 |
| Boehringer Ingelheim | 6 | $80 |
| Amgen | 6 | $79 |
| Sunovion Pharmaceuticals Inc. | 4 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 3 | $35 |
| Endo Pharmaceuticals Inc. | 2 | $26 |
| Avanir Pharmaceuticals, Inc. | 2 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Pfizer | 1 | $14 |
| Merck | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,985 in reported general payments places this provider in the 75th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Mercerville
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.